Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance

The Journal of Infectious Diseases
T RybkineL Gutmann

Abstract

The low-affinity penicillin-binding protein (PBP) 5 is the main beta-lactam target and is responsible for resistance to this class of antibiotics in Enterococcus faecium. The PBP 5 variants of 15 clinical isolates (including 8 resistant to vancomycin) with different levels of beta-lactam resistance were analyzed. Most of the highly beta-lactam-resistant isolates produced small quantities of PBP 5 of low affinity. This was associated with particular amino acid substitutions: an Ala or Ile for Thr-499, a Glu for Val-629, and a Pro for Ser-667. A change of Met-485 to Thr or Ala (adjacent to the conserved SDN box) was observed in isolates with MICs of ampicillin of 64 or 128 microg/mL, respectively. In the 2 most resistant isolates, with MICs of ampicillin of 256 microg/mL, an additional Ser was present just after Ser-466. Thus, particular point mutations in PBP 5 and combinations thereof may lead to high-level beta-lactam resistance in E. faecium.

Citations

Feb 11, 2011·Current Infectious Disease Reports·Subramanian Swaminathan, George J Alangaden
Mar 9, 2000·The New England Journal of Medicine·B E Murray
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H S Gold
Apr 17, 2001·Antimicrobial Agents and Chemotherapy·L B RiceS D Rudin
Oct 4, 2003·Journal of Bacteriology·Frédéric SapunaricJacques Coyette
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Stein Christian MohnNina Langeland
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Louis B RiceLaurent Gutmann
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Louis B RiceRebecca Hutton-Thomas
Feb 11, 2011·Journal of Applied Oral Science : Revista FOB·Ellen Cristina Gaetti-JardimElerson Gaetti-Jardim
Jun 6, 2007·Expert Review of Anti-infective Therapy·Alfred GinGeorge G Zhanel
Nov 6, 2007·Expert Opinion on Emerging Drugs·Malcolm G P Page
Jul 23, 2004·Expert Opinion on Investigational Drugs·Malcolm G P Page
May 9, 2015·The Journal of Antimicrobial Chemotherapy·Brian J Werth, April N Abbott
Aug 17, 2006·FEMS Microbiology Reviews·Pauline MacheboeufAndréa Dessen
Feb 6, 2008·FEMS Microbiology Reviews·André ZapunThierry Vernet
Feb 19, 2008·FEMS Immunology and Medical Microbiology·Janetta TopMarc Bonten
Dec 3, 2014·Current Opinion in Pharmacology·Jean-Marie Frère, Malcolm G P Page
Jul 1, 2017·Nihon saikingaku zasshi. Japanese journal of bacteriology·Yasuyoshi Ike
Nov 9, 2016·Antimicrobial Agents and Chemotherapy·Maria Camila MontealegreBarbara E Murray
Sep 4, 2014·Antimicrobial Agents and Chemotherapy·Ester PiettaBarbara E Murray
Mar 17, 2012·Nature Reviews. Microbiology·Cesar A Arias, Barbara E Murray
Apr 5, 2000·The Journal of Biological Chemistry·J L MainardiL Gutmann
May 16, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Vanessa SilvaPatricia Poeta
Jan 15, 2019·Tropical Animal Health and Production·Özkan Aslantaş
Jan 29, 2019·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Hosein DarehkordiRoya Ahmadrajabi
Feb 1, 2019·Clinical Microbiology Reviews·Mónica García-Solache, Louis B Rice

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.